SEC 13F Intelligence

Geneva Partners, LLC / EW

Geneva Partners, LLC’s Edwards Lifesciences Corp Position

Does Geneva Partners, LLC own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 12.2K shares worth $3M in Q4 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q4 2019
Shares
12.2K
% of Portfolio
+1.96%
Quarters Held
4
position exited

Position History EW

Reported value by quarter
Q1 ’19: $3MQ1 ’19Q2 ’19: $3MQ2 ’19Q3 ’19: $3MQ3 ’19Q4 ’19: $3MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 201912.2K$3M+1.96%
Q3 201914.0K$3M+2.39%
Q2 201913.6K$3M+2.03%
Q1 201915.4K$3M+2.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Geneva Partners, LLC’s full portfolio or all institutional holders of EW.